Email Alert | RSS

北京大学学报（医学版） ›› 2022, Vol. 54 ›› Issue (2): 304-314. doi: 10.19723/j.issn.1671-167X.2022.02.018

• 论著 • 上一篇    下一篇

显微外科手术与血管内栓塞治疗硬脊膜动静脉瘘临床疗效比较的meta分析

袁昌巍,王盈进,张书杰,沈胜利,段鸿洲()   

  1. 北京大学第一医院神经外科,北京 100034
  • 收稿日期:2020-02-12 出版日期:2022-04-18 发布日期:2022-04-13
  • 通讯作者: 段鸿洲 E-mail:duanhongzhou@126.com
  • 基金资助:
    国家自然科学基金(81541119);北京大学第一医院交叉临床研究专项资助项目;北京大学第一医院青年临床研究专项基金(2019CR02)

Clinical outcomes following microsurgery and endovascular embolization in the management of spinal dural arteriovenous fistula: A meta-analysis study

YUAN Chang-wei,WANG Ying-jin,ZHANG Shu-jie,SHEN Sheng-li,DUAN Hong-zhou()   

  1. Department of Neurosurgery, Peking University First Hospital, Beijing 100034, China
  • Received:2020-02-12 Online:2022-04-18 Published:2022-04-13
  • Contact: Hong-zhou DUAN E-mail:duanhongzhou@126.com
  • Supported by:
    National Natural Science Foundation of China(81541119);Peking University First Hospital Cross Clinical Study Foundation;Youth Clinical Research Project of Peking University First Hospital(2019CR02)

RICH HTML

 12   

PDF (PC)

89

摘要：

目的: 通过meta分析比较显微外科手术与血管内栓塞治疗硬脊膜动静脉瘘的临床疗效。方法: 计算机检索PubMed、Embase、Web of Science、Cochrane临床试验数据库、中国知网、万方数据库、中国生物医学文献数据库(Chinese BioMedical Literature Database,CBM),检索时间从数据库建库至2019年12月,纳入采用显微外科手术和血管内栓塞治疗硬脊膜动静脉瘘的所有中英文文献。使用RevMan 5.3软件进行统计学分析,评估术后早期失败率、远期复发、神经功能恢复程度、并发症情况,比较两种治疗方式对硬脊膜动静脉瘘的临床疗效,并对血管内栓塞治疗进行亚组分析。结果: 纳入文献46篇,共1 958例硬脊膜动静脉瘘患者,其中935例采用显微外科手术治疗,1 023例采用血管内栓塞治疗,漏斗图显示未见明显发表偏倚。经meta分析结果显示,显微外科手术早期治疗失败的发生率低于血管内栓塞治疗(OR=0.20, 95%CI: 0.13~0.30, P<0.05),远期复发率也低于血管内栓塞治疗(OR=0.36, 95%CI: 0.22~0.58, P<0.05),显微外科手术治疗后患者神经功能改善情况优于血管内栓塞治疗的患者(OR=2.86, 95%CI: 1.36~5.99, P<0.05),两种治疗方式患者并发症的发生率差异无统计学意义(OR=1.52, 95%CI: 0.88~2.64, P=0.14)。血管内栓塞治疗的患者中,使用Onyx胶进行栓塞比使用α-氰基丙烯酸正丁酯(n-butyl 2-cyanoacrylate,NBCA胶)有更高的治疗失败或复发风险,差异有统计学意义(OR=4.70, 95%CI: 1.55~14.28, P<0.05)。结论: 虽然血管内栓塞治疗硬脊膜动静脉瘘的应用日趋广泛,但显微外科手术所获得的临床疗效仍明显优于血管内栓塞治疗。

关键词: 硬膜, 动静脉瘘, 显微外科手术, 栓塞, 治疗性, Meta分析

Abstract:

Objective: To compare the clinical effect of microsurgery and endovascular embolization in the treatment of spinal dural arteriovenous fistula (SDAVF) by meta-analysis. Methods: A systematic review was performed to retrieve all relevant literature about surgical treatment or endovascular embolization of SDAVF up to December 2019 through PubMed, Embase, Web of Science, Cochrane Central Register of Controlled Trials Results, CNKI, Wanfang Data, and SinoMed. The Chinese and English key words included: “SDAVF”, “spinal dural arteriovenous fistula”, “spinal AVM”, “spinal vascular malformation and treatment”. The included studies were evaluated using the Newcastle-Ottawa scale. The early failure rate, long-term recurrence, neurological recovery, and complications were evaluated and the clinical effects of the two methods in the treatment of SDAVF were compared by using RevMan 5.3 software. And a further subgroup analysis of the therapeutic effect of endovascular embolization with different embolic agents was conducted. Results: A total of 46 studies involving 1 958 cases of SDAVF were included, in which 935 cases were treated by microsurgery and 1 023 cases were treated by endovascular embolization. The funnel plot demonstrated that there was no publication bias. The results of meta-analysis showed that the incidence of early surgical failure was lower than that of endovascular embolization (OR=0.20, 95%CI: 0.13-0.30, P<0.05), and the long-term recurrence was also lower than that of endovascular embolization (OR=0.36, 95%CI: 0.22-0.58, P<0.05). The improvement of neurological function in the surgical patients is significantly higher than that in the patients treated with endovascular embolization (OR=2.86, 95%CI: 1.36-5.99, P<0.05). There was no significant difference in the occurrence of complications in these two groups (OR=1.52, 95%CI: 0.88-2.64, P=0.14). In the cases of endovascular embolization, the risk of treatment failure or recurrence was higher with Onyx glue than with n-butyl 2-cyanoacrylate (NBCA), and the difference was statistically significant (OR=4.70, 95%CI: 1.55-14.28, P<0.05). Conclusion: Although the treatment of dural arteriovenous fistulas by intravascular embolization has been widely used, the clinical effect of microsurgery is still better than that of endovascular embolization. Large scale and high-quality randomized controlled trials are required to validate the efficacy and safety of endovascular treatment in SDAVF patients.

Key words: Dura mater, Arteriovenous fistula, Microsurgery, Embolization, therapeutic, Meta-analysis

中图分类号: 

  • R744.1

表1

纳入文献的一般情况"

No. Author Year Study
type		 S E Follow-up/
months		 Initial failure
(S/E)		 Late recurrence
(S/E)		 Complications: S Complications: E NOS
score
1 Ushikoshi et al[5] 1999 RS 6 6 6 0/2 1/Not reported 1 transient deterioration
of paraparesis;
1 hemorrhage in
the medulla
oblongata		 2 transient deterioration
of paraparesis;
1 transient
L4 radiculopathy		 6
2 Song et al[6] 2001 RS 7 23 10.5 0/7 2/5 Not reported Not reported 6
3 Jellema et al[7] 2005 RS 12 24 1-120 0/0 0/8 Not reported Not reported 5
4 Andres et al[8] 2008 RS 4 17 12 0/4 Not reported/
Not reported		 0 0 5
5 Narvid et al[9] 2008 RS 24 39 49 4/7 0/5 0 0 7
6 Park et al[10] 2008 RS 1 17 12-160 0/2 0/1 0 1 transient aortic
intimal dissection		 5
7 Sherif et al[11] 2008 RS 7 19 24 0/0 0/2 0 0 5
8 Hessler et al[12] 2010 RS 54 102 24 0/21 2/6 Not reported Not reported 5
9 Shinoyama et al[13] 2010 RS 17 3 57 0/0 0/2 Not reported Not reported 6
10 Kaufmann et al[14] 2011 RS 33 1 Not reported 3/0 Not reported/
Not reported		 Not reported Not reported 5
11 Ruiz-Juretschke
et al[15]		 2011 RS 10 9 36 1/2 1/2 1 CSF fistula;
1 septic shock
secondary to
colon perforation		 1 spinal cord
infarction		 6
12 Cenzato et al[16] 2012 RS 55 10 36 0/3 Not reported/
Not reported		 0 0 5
13 Cho et al[17] 2013 RS 5 23 20 0/2 0/2 1 CSF leak 3 temporary
thromboembolic symtoms;
1 temporary
radiculomedullary
artery spasm;
1 asymptomatic
aortic arch dissection		 5
14 Clark et al[18] 2013 RS 8 15 32 0/2 1/6 Not reported 0 6
15 Gemmete et al[19] 2013 RS 4 29 Not reported 0/3 0/2 0 1 transient neurological
worsening due to
penetration of
embolic material
deep into
venous system		 6
16 Inagawa et al[20] 2013 RS 2 12 5-97 0/4 0/1 0 1 transient gait
disturbance;
1 permanent
gait disturbance		 5
17 Kirsch et al[21] 2013 RS 17 61 18 0/14 Not reported/
Not reported		 1 transient
radicular pain;
1 transient paraperesis;
1 CSF leak		 1 spinal cord infarction 5
18 Takai et al[22] 2013 RS 23 4 14 0/0 Not reported/
Not reported		 1 CSF fistula;
1 wrong-level
laminectomy,
1 idiopathic
venous thrombosis		 0 4
No. Author Year Study
type		 S E Follow-up/
months		 Initial failure
(S/E)		 Late recurrence
(S/E)		 Complications: S Complications: E NOS
score
19 Gokhale et al[23] 2014 RS 17 10 24 0/0 0/3 2 wound infections 1 spinal cord infarction 5
20 Qi et al[24] 2014 RS 40 12 Not reported 0/5 0/3 1 wound infection;
1 haematoma		 0 4
21 Rashad et al[25] 2014 RS 9 3 3-24 0/1 0/1 Not reported Not reported 6
22 Yen et al[26] 2014 RS 2 10 6 0/2 Not reported/
Not reported		 0 1 spinal cord
infarction; 1 brainstem
and cerebellar infarction		 4
23 Chibbaro et al[27] 2015 RS 30 120 Not reported 0/2 0/6 0 Not reported 5
24 Özkan et al[28] 2015 RS 25 5 34.8 2/2 0/0 1 epidural haematoma 0 5
25 Shin et al[29] 2015 RS 6 9 27 0/0 Not reported/
Not reported		 0 1 temporary cord
ischaemia		 5
26 Sri et al[30] 2015 RS 2 36 10 0/18 0/1 Not reported Not reported 5
27 Zogopoulos et al[31] 2016 RS 3 11 25.5 0/3 0/1 1 CSF leak 1 transient lower
extremity weakness		 6
28 Lee et al[32] 2016 RS 5 32 >24 0/12 Not reported/
Not reported		 1 pseudomeningocele 0 5
29 Sasamori et al[33] 2016 RS 19 31 81.2 1/6 0/3 1 wound infection;
1 epidural haematoma;
1 subdural haematoma		 1 spinal cord infarct;
1 aortic dissection;
two extravascular
dislocations of a
guide wire		 6
30 Adrianto et al[34] 2017 RS 5 4 37 2/1 Not reported/
Not reported		 Not reported Not reported 6
31 Durnford et al[35] 2017 RS 11 22 63 0/10 0/2 1 wound infection;
1 pseudomeningocele		 2 intercostal artery
rupture with
retroperitoneal
haematoma; 1 DVT		 6
32 Gross et al[36] 2017 RS 43 28 16 0/14 Not reported/
Not reported		 1 epidural haematoma;
2 wound infections;
3 CSF leaks		 2 radicular artery
ruptures; 1 transient
worsened numbness;
1 lower extremity
weakness		 7
33 Koch et al[37] 2017 RS 14 20 9 0/7 0/0 1 symptomatic
pseudomeningocele;
1 wound seroma		 2 microcatheter
ruptures		 6
34 Ma et al[38] 2018 PS 81 13 12 0/3 0/1 1 surgical site infection 0 8
35 Bretonnier et al[39] 2019 RS 23 40 S: 21.7;
E: 34.3		 1/12 6/3 2 epidural haematoma;
1 CSF leak;
1 wound infection		 1 spinal cord infarction 6
36 Huang et al[40] 2003 RS 8 7 2-24 0/0 0/2 Not reported Not reported 5
37 Li et al[41] 2003 RS 98 12 3-120 0/0 Not reported/3 Not reported Not reported 5
38 Pan et al[42] 2005 RS 11 38 12-48 0/0 Not reported/0 Not reported Not reported 6
39 Yu et al[43] 2008 RS 16 5 2-120 1/1 Not reported/
Not reported		 Not reported Not reported 4
40 Yu et al [44] 2012 RS 9 2 6-24 0/0 0/0 Not reported Not reported 5
41 Li et al[45] 2013 RS 14 9 6-30 0/2 0/2 Not reported Not reported 5
42 Qi XQ et al[46] 2014 RS 40 12 6-72 5/2 Not reported/2 1 wound infections;
1 epidural haematoma		 Not reported 5
43 Zhao[47] 2014 RS 29 21 6-12 0/0 0/0 Not reported Not reported 4
44 Cai et al[48] 2018 RS 11 2 6 0/0 Not reported/
Not reported		 Not reported Not reported 4
45 Zhang et al[49] 2018 RS 10 34 9 0/0 0/6 0 Not reported 5
46 Hu[50] 2019 RS 28 13 10-65 0/0 0/2 Not reported Not reported 5

图1

文献筛选流程图"

图2

显微外科手术与血管内栓塞治疗早期失败率的比较"

图3

显微外科手术与血管内栓塞治疗远期复发率的比较"

图4

显微外科手术与血管内栓塞治疗患者神经功能改善情况的比较"

图5

显微外科手术与血管内栓塞治疗并发症的比较"

图6

Onyx胶与NBCA治疗失败的比较"

图7

早期失败(A)、远期复发(B)、神经功能改善(C)、并发症(D)的漏斗图分析"

[1] 马廉亭, 龚杰, 樊光辉, 等. 脊髓静脉高压综合征的诊断治疗策略与方法[J]. 中华神经外科志, 2010, 26(11):1007-1009.
[2] 王刚, 佟志勇, 刘源, 等. 硬脊膜动静脉瘘的临床特点和治疗现状[J]. 医学综述, 2018, 24(3):527-532.
[3] Brinjikji W, Nasr DM, Morris JM, et al. Clinical outcomes of patients with delayed diagnosis of spinal dural arteriovenous fistulas[J]. AJNR Am J Neuroradiol, 2016, 37(2):380-386.
doi: 10.3174/ajnr.A4504
[4] Aminoff MJ, Logue V. The prognosis of patients with spinal vascular malformations[J]. Brain, 1974, 97(1):211-218.
pmid: 4434169
[5] Ushikoshi S, Hida K, Kikuchi Y, et al. Functional prognosis after treatment of spinal dural arteriovenous fistulas[J]. Neurol Med Chir (Tokyo), 1999, 39(3):206-213.
doi: 10.2176/nmc.39.206
[6] Song JK, Vinuela F, Gobin YP, et al. Surgical and endovascular treatment of spinal dural arteriovenous fistulas: Long-term disability assessment and prognostic factors[J]. J Neurosurg, 2001, 94(2 Suppl):199-204.
pmid: 11302620
[7] Jellema K, Sluzewski M, van Rooij WJ, et al. Embolization of spinal dural arteriovenous fistulas: Importance of occlusion of the draining vein[J]. J Neurosurg Spine, 2005, 2(5):580-583.
doi: 10.3171/spi.2005.2.5.0580
[8] Andres RH, Barth A, Guzman R, et al. Endovascular and surgical treatment of spinal dural arteriovenous fistulas[J]. Neuro-radiology, 2008, 50(10):869-876.
[9] Narvid J, Hetts SW, Larsen D, et al. Spinal dural arteriovenous fistulae: Clinical features and long-term results[J]. Neurosurge-ry, 2008, 62(1):159-167.
[10] Park SB, Han MH, Jahng TA, et al. Spinal dural arteriovenous fistulas: Clinical experience with endovascular treatment as a primary therapeutic modality[J]. J Korean Neurosurg Soc, 2008, 44(6):364-369.
doi: 10.3340/jkns.2008.44.6.364
[11] Sherif C, Gruber A, Bavinzski G, et al. Long-term outcome of a multidisciplinary concept of spinal dural arteriovenous fistulae treatment[J]. Neuroradiology, 2008, 50(1):67-74.
doi: 10.1007/s00234-007-0303-4
[12] Hessler C, Regelsberger J, Grzyska U, et al. Therapeutic clues in spinal dural arteriovenous fistulas: A 30 year experience of 156 cases[J]. Cent Eur Neurosurg, 2010, 71(1):8-12.
doi: 10.1055/s-0029-1224195 pmid: 19784910
[13] Shinoyama M, Endo T, Takahash T, et al. Long-term outcome of cervical and thoracolumbar dural arteriovenous fistulas with emphasis on sensory disturbance and neuropathic pain[J]. World Neurosurg, 2010, 73(4):401-408.
doi: 10.1016/j.wneu.2010.01.003 pmid: 20849800
[14] Kaufmann TJ, Morris JM, Saladino A, et al. Magnetic resonance imaging findings in treated spinal dural arteriovenous fistulas: lack of correlation with clinical outcomes[J]. J Neurosurg Spine, 2011, 14(4):548-554.
doi: 10.3171/2010.11.SPINE10178
[15] Ruiz-Juretschke F, Perez-Calvo JM, Castro E, et al. A single-center, long-term study of spinal dural arteriovenous fistulas with multidisciplinary treatment[J]. J Clin Neurosci, 2011, 18(12):1662-1666.
doi: 10.1016/j.jocn.2011.03.008 pmid: 22019434
[16] Cenzato M, Debernardi A, Stefini R, et al. Spinal dural arteriovenous fistulas: Outcome and prognostic factors[J]. Neurosurg Focus, 2012, 32(5):E11.
[17] Cho WS, Kim KJ, Kwon OK, et al. Clinical features and treatment outcomes of the spinal arteriovenous fistulas and malformation: Clinical article[J]. J Neurosurg Spine, 2013, 19(2):207-216.
doi: 10.3171/2013.4.SPINE12732
[18] Clark S, Powell G, Kandasamy J, et al. Spinal dural arteriovenous fistulas: Presentation, management and outcome in a single neurosurgical institution[J]. Br J Neurosurg, 2013, 27(4):465-470.
doi: 10.3109/02688697.2012.752433
[19] Gemmete JJ, Chaudhary N, Elias AE, et al. Spinal dural arteriovenous fistulas: Clinical experience with endovascular treatment as a primary therapy at 2 academic referral centers[J]. AJNR Am J Neuroradiol, 2013, 34(10):1974-1979.
doi: 10.3174/ajnr.A3522
[20] Inagawa S, Yamashita S, Hiramatsu H, et al. Clinical results after the multidisciplinary treatment of spinal arteriovenous fistulas[J]. Jpn J Radiol, 2013, 31(7):455-464.
doi: 10.1007/s11604-013-0216-6
[21] Kirsch M, Berg-Dammer E, Musahl C, et al. Endovascular management of spinal dural arteriovenous fistulas in 78 patients[J]. Neuroradiology, 2013, 55(3):337-343.
doi: 10.1007/s00234-013-1134-0 pmid: 23334434
[22] Takai K, Kin T, Oyama H, et al. Three-dimensional angioarchitecture of spinal dural arteriovenous fistulas, with special reference to the intradural retrograde venous drainage system[J]. J Neurosurg Spine, 2013, 18(4):398-408.
doi: 10.3171/2013.1.SPINE12305
[23] Gokhale S, Khan SA, McDonagh DL, et al. Comparison of surgical and endovascular approach in management of spinal dural arteriovenous fistulas: A single center experience of 27 patients[J]. Surg Neurol Int, 2014, 5:7.
[24] Qi X, Lv L, Han K, et al. Analysis of the embolization spinal dural arteriovenous fistula and surgical treatments on 52 cases of the patients[J]. Int J Clin Exp Med, 2014, 7(9):3062-3071.
[25] Rashad S, Abdel-Bary M, Aziz W, et al. Management of spinal dural arterio-venous fistulas: Report of 12 cases and review of lite-rature[J]. Clin Neurol Neurosurg, 2014, 125:81-86.
doi: 10.1016/j.clineuro.2014.07.028
[26] Yen PP, Ritchie KC, Shankar JJ. Spinal dural arteriovenous fistula: Correlation between radiological and clinical findings[J]. J Neurosurg Spine, 2014, 21(5):837-842.
doi: 10.3171/2014.7.SPINE13797
[27] Chibbaro S, Gory B, Marsella M, et al. Surgical management of spinal dural arteriovenous fistulas[J]. J Clin Neurosci, 2015, 22(1):180-183.
doi: 10.1016/j.jocn.2014.07.024
[28] Özkan N, Kreitschmann-Andermahr I, Goerike SL, et al. Single center experience with treatment of spinal dural arteriovenous fistulas[J]. Neurosurg Rev, 2015, 38(4):683-692.
doi: 10.1007/s10143-015-0645-z
[29] Shin DA, Park KY, Ji GY, et al. The use of magnetic resonance imaging in predicting the clinical outcome of spinal arteriovenous fistula[J]. Yonsei Med J, 2015, 56(2):397-402.
doi: 10.3349/ymj.2015.56.2.397
[30] Sri D, Higgins N, Laing R. Combined radiological and surgical management of spinal dural fistulas[J]. Br J Neurosurg, 2015, 29(4):505-507.
doi: 10.3109/02688697.2015.1012049
[31] Zogopoulos P, Nakamura H, Ozaki T, et al. Endovascular and surgical treatment of spinal dural arteriovenous fistulas: Assessment of post-treatment clinical outcome[J]. Neurol Med Chir (Tokyo), 2016, 56(1):27-32.
doi: 10.2176/nmc.oa.2015-0100
[32] Lee J, Lim YM, Suh DC, et al. Clinical presentation, imaging findings, and prognosis of spinal dural arteriovenous fistula[J]. J Clin Neurosci, 2016, 26:105-109.
doi: 10.1016/j.jocn.2015.06.030
[33] Sasamori T, Hida K, Yano S, et al. Long-term outcomes after surgical and endovascular treatment of spinal dural arteriovenous fistulae[J]. Eur Spine J, 2016, 25(3):748-754.
doi: 10.1007/s00586-015-3887-0 pmid: 25801745
[34] Adrianto Y, Yang KH, Koo HW, et al. Concomitant origin of the anterior or posterior spinal artery with the feeder of a spinal dural arteriovenous fistula (SDAVF)[J]. J Neurointerv Surg, 2017, 9(4):405-410.
doi: 10.1136/neurintsurg-2016-012267 pmid: 27060157
[35] Durnford AJ, Hempenstall J, Sadek AR, et al. Degree and duration of functional improvement on long-term follow-up of spinal dural arteriovenous fistulae occluded by endovascular and surgical treatment[J]. World Neurosurg, 2017, 107:488-494.
doi: S1878-8750(17)31240-8 pmid: 28774761
[36] Gross BA, Albuquerque FC, Moon K, et al. Validation of an “endovascular-first” approach to spinal dural arteriovenous fistulas: An intention-to-treat analysis[J]. J Neurointerv Surg, 2017, 9(1):102-105.
doi: 10.1136/neurintsurg-2016-012333
[37] Koch MJ, Stapleton CJ, Agarwalla PK, et al. Open and endovascular treatment of spinal dural arteriovenous fistulas: A 10-year experience[J]. J Neurosurg Spine, 2017, 26(4):519-523.
doi: 10.3171/2016.9.SPINE16394
[38] Ma Y, Chen S, Peng C, et al. Clinical outcomes and prognostic factors in patients with spinal dural arteriovenous fistulas: A prospective cohort study in two Chinese centres[J]. BMJ Open, 2018, 8(1):e019800.
doi: 10.1136/bmjopen-2017-019800
[39] Bretonnier M, Hénaux PL, Gaberel T, et al. Spinal dural arteriovenous fistulas: Clinical outcome after surgery versus embolization: A retrospective study[J]. World Neurosurg, 2019, 127:e943-e949.
doi: 10.1016/j.wneu.2019.04.005
[40] 黄承光, 白如林, 陈左权, 等. 15例脊髓硬脊膜动静脉瘘栓塞和手术治疗[J]. 中华神经外科杂志, 2003, 19(5):340.
[41] 李萌, 张鸿祺, 支兴龙, 等. 硬脊膜动静脉瘘的诊断和治疗[J]. 中华外科杂志, 2003, 41(2):99-102.
[42] 潘力, 马廉亭, 余泽, 等. 硬脊膜动静脉瘘的诊治探讨[J]. 中华外科杂志, 2005, 43(5):330-340.
[43] 于加省, 陈劲草, 雷霆, 等. 骶部硬脊膜动静脉瘘的诊断与治疗[J]. 华中科技大学学报(医学版), 2008, 37(3):409-411.
[44] 于加省, 何跃, 陈如东, 等. 硬脊膜动静脉瘘的显微手术与血管内栓塞治疗[J]. 中华神经外科杂志, 2012, 28(7):706-709.
[45] 李治国, 潘力术, 杨铭, 等. 硬脊膜动静脉瘘的治疗策略的选择. 中华中青年神经外科交流协会第二届学术大会论文集[C]. 苏州: 中华中青年神经外科交流协会, 2013: 314-318.
[46] 齐向前, 韩凯伟, 许政, 等. 硬脊膜动静脉瘘的栓塞和手术治疗[J]. 中国微侵袭神经外科杂志, 2014, 19(8):345-348.
[47] 赵丹. 血管内栓塞治疗颅颈交界区硬脊膜动静脉瘘50例临床分析[J]. 大家健康(学术版), 2014, 8(15):291.
[48] 蔡明俊, 马廉亭, 杨铭, 等. 硬脊膜动静脉瘘的治疗分析[J]. 中国临床神经外科杂志, 2018, 23(6):392-394.
[49] 张仁德, 王蒙, 王俊宽, 等. 硬脊膜动静脉瘘的治疗及预后相关因素分析[J]. 郑州大学学报(医学版), 2018, 53(4):529-534.
[50] 胡智洪. 41例脊髓硬脊膜动静脉瘘患者手术方式、预后回顾性分析研究[D]. 四川泸州: 西南医科大学, 2019.
[51] Thron A. Spinale durale arteriovenöse Fisteln [Spinal dural arteriovenous fistulas][J]. Radiologe, 2001, 41(11):955-960.
pmid: 11765536
[52] Guillevin R, Vallee JN, Cormier E, et al. N-butyl 2-cyanoacrylate embolization of spinal dural arteriovenous fistulae: CT evaluation, technical features, and outcome prognosis in 26 cases[J]. AJNR Am J Neuroradiol, 2005, 26(4):929-935.
[53] Nogueira RG, Dabus G, Rabinov JD, et al. Onyx embolization for the treatment of spinal dural arteriovenous fistulae: Initial expe-rience with long-term follow-up. Technical case report[J]. Neurosurgery, 2009, 64(1):E197-E198.
doi: 10.1227/01.NEU.0000335157.90249.97
[54] Steinmetz MP, Chow MM, Krishnaney AA, et al. Outcome after the treatment of spinal dural arteriovenous fistulae: A contemporary single-institution series and meta-analysis[J]. Neurosurgery, 2004, 55(1):77-88.
pmid: 15214976
[55] Bakker NA, Uyttenboogaart M, Luijckx GJ, et al. Recurrence rates after surgical or endovascular treatment of spinal dural arteriovenous fistulas: A meta-analysis[J]. Neurosurgery, 2015, 77(1):137-144.
doi: 10.1227/NEU.0000000000000727
[56] 丁璇, 王志刚, 沈寻, 等. NBCA和ONYX栓塞治疗不同类型脑动静脉畸形的对比研究[J]. 中华神经外科杂志, 2006, 22(8):464-466.
[57] Blackburn SL, Kadkhodayan Y, Ray WZ, et al. Onyx is asso-ciated with poor venous penetration in the treatment of spinal dural arteriovenous fistulas[J]. J Neurointerv Surg, 2014, 6(7):536-540.
doi: 10.1136/neurintsurg-2013-010779 pmid: 23943815
[58] Marquardt G, Berkefeld J, Seifert V, et al. Preoperative coil marking to facilitate intraoperative localization of spinal dural arteriovenous fistulas[J]. Eur Spine J, 2009, 18(8):1117-1120.
doi: 10.1007/s00586-009-0946-4 pmid: 19330362
[1] 穆东亮,薛铖,安彬,王东信. 硬膜外阻滞与结直肠癌患者术后远期生存状态的关系:一项倾向性评分匹配的回顾性研究[J]. 北京大学学报（医学版）, 2021, 53(6): 1152-1158.
[2] 林国中, 马长城, 王振宇, 谢京城, 刘彬, 陈晓东. 颈1~2硬膜外神经鞘瘤的显微微创治疗[J]. 北京大学学报（医学版）, 2021, 53(3): 586-589.
[3] 冯菁楠,高乐,孙一鑫,杨继春,邓思危,孙凤,詹思延. Xpert®MTB/RIF对我国人群活动性肺结核和利福平耐药肺结核诊断准确性的meta分析[J]. 北京大学学报（医学版）, 2021, 53(2): 320-326.
[4] 朱冯赟智,邢晓燕,汤晓菲,李依敏,邵苗,张学武,李玉慧,孙晓麟,何菁. 肌炎合并血栓栓塞患者的临床及免疫学特征[J]. 北京大学学报（医学版）, 2020, 52(6): 995-1000.
[5] 高健,胡立宝,陈尘,郅新,徐涛. 经皮肾镜去石术后出血的介入治疗[J]. 北京大学学报（医学版）, 2020, 52(4): 667-671.
[6] 曾保起,于树青,陈瑶,翟伟,刘斌,詹思延,孙凤. 主动脉瓣生物瓣膜安全性的系统评价与meta分析[J]. 北京大学学报（医学版）, 2020, 52(3): 547-556.
[7] 林国中,王振宇,谢京城,刘彬,马长城,陈晓东. 内含终丝的骶管囊肿21例临床研究[J]. 北京大学学报（医学版）, 2020, 52(3): 582-585.
[8] 赵海燕,樊东升,韩金涛. 重度颈内动脉狭窄伴未破裂动脉瘤的治疗策略[J]. 北京大学学报（医学版）, 2019, 51(5): 829-834.
[9] 张志刚,刘新民. 急性肾梗死的临床特征:单中心52例临床分析[J]. 北京大学学报（医学版）, 2019, 51(5): 863-869.
[10] 张祎然,饶烽,皮伟,张培训,姜保国. 股骨近端防旋髓内钉与动力髋螺钉治疗不稳定型粗隆间骨折的meta分析[J]. 北京大学学报（医学版）, 2019, 51(3): 493-500.
[11] 张玮,张培训. 老年髋部骨折患者围手术期血栓预防时限分析[J]. 北京大学学报（医学版）, 2019, 51(3): 501-504.
[12] 刘爽,郭雨龙,杨静逸,王维,徐健. 间充质干细胞治疗系统性红斑狼疮有效性的meta分析[J]. 北京大学学报（医学版）, 2018, 50(6): 1014-1021.
[13] 顾婕昱,陆翠,石慧,杨程德. 14例恶性抗磷脂综合征病例报道及临床分析[J]. 北京大学学报（医学版）, 2018, 50(6): 1033-1038.
[14] 郭李盈,刘晓昕,李子圆,覃小雅,范则杨,李真真,关海涛,宋莉,邹英华,范田园. 空白及载阿霉素的聚丙烯酸栓塞微球的制备与评价[J]. 北京大学学报（医学版）, 2018, 50(6): 1070-1077.
[15] 赵灿，胡京敏，郭丹杰. 血浆D二聚体临界值联合Wells量表对可疑肺栓塞的除外价值[J]. 北京大学学报(医学版), 2018, 50(5): 828-832.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 王新宇,崔哲,和清源,邓湘宁,郭歌,冯新恒,冯杰莉. 斑点追踪技术评价中国优秀男子举重运动员心脏的改变[J]. 北京大学学报（医学版）, 2021, 53(5): 832 -837 .
[2] 刘云松,周倜,叶红强. 前牙美学修复的整体策略及细节剖析[J]. 北京大学学报（医学版）, 2022, 54(1): 1 -6 .
[3] 张学武. 痛风关节炎治疗中几个备受关注的问题[J]. 北京大学学报（医学版）, 2021, 53(6): 1017 -1019 .
[4] 娄雪,廖莉,李兴珺,王楠,刘爽,崔若玫,徐健. 类风湿关节炎患者外周血TWEAK基因启动子区甲基化状态及其表达[J]. 北京大学学报（医学版）, 2021, 53(6): 1020 -1025 .
[5] 钟华,徐丽玲,白明欣,苏茵. 类风湿关节炎患者趋化因子CXCL9和CXCL10在骨侵蚀中的作用[J]. 北京大学学报（医学版）, 2021, 53(6): 1026 -1031 .
[6] 郭应禄. 夯实人才培养,实现我国泌尿外科奋斗目标[J]. 北京大学学报（医学版）, 2021, 53(4): 633 -634 .
[7] 蒋青,张雨. 新形势下运动损伤特点及细胞生物治疗的应用前景和挑战[J]. 北京大学学报（医学版）, 2021, 53(5): 828 -831 .
[8] 刘承,马潞林. 前入路机器人辅助前列腺根治性切除术中改善排尿控制的经验[J]. 北京大学学报（医学版）, 2021, 53(4): 635 -639 .
[9] 于妍斐,何世明,吴宇财,熊盛炜,沈棋,李妍妍,杨风,何群,李学松. 延胡索酸水合酶缺陷型肾细胞癌的临床病理特征及预后[J]. 北京大学学报（医学版）, 2021, 53(4): 640 -646 .
[10] 王立新, 许晓, 倪耀丰, 孙海涛, 余日月, 魏世成. 载药脂质体修饰的聚醚醚酮植入物的抑菌和骨整合性能[J]. 北京大学学报（医学版）, 2021, 53(4): 758 -763 .
ISSN 1671-167X
CN 11-4691/R
主管单位：中华人民共和国教育部
主办单位：北京大学
地址： 北京市海淀区学院路38号 北京大学医学部 《北京大学学报（医学版）》
邮编：100191
电话：010-82801551
Email： xbbjb2@bjmu.edu.cn

《北京大学学报（医学版）》
微信公众号
版权所有 © 2018 《北京大学学报（医学版）》编辑部